FBLG
Price
$0.60
Change
-$0.00 (-0.00%)
Updated
Jul 7 closing price
Capitalization
23.74M
57 days until earnings call
VRDN
Price
$15.87
Change
-$0.03 (-0.19%)
Updated
Jul 8, 12:37 PM (EDT)
Capitalization
1.3B
29 days until earnings call
Interact to see
Advertisement

FBLG vs VRDN

Header iconFBLG vs VRDN Comparison
Open Charts FBLG vs VRDNBanner chart's image
FibroBiologics
Price$0.60
Change-$0.00 (-0.00%)
Volume$338.5K
Capitalization23.74M
Viridian Therapeutics
Price$15.87
Change-$0.03 (-0.19%)
Volume$100
Capitalization1.3B
FBLG vs VRDN Comparison Chart in %
Loading...
FBLG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FBLG vs. VRDN commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBLG is a Buy and VRDN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 08, 2025
Stock price -- (FBLG: $0.61 vs. VRDN: $15.89)
Brand notoriety: FBLG and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBLG: 79% vs. VRDN: 120%
Market capitalization -- FBLG: $23.74M vs. VRDN: $1.3B
FBLG [@Biotechnology] is valued at $23.74M. VRDN’s [@Biotechnology] market capitalization is $1.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBLG’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • FBLG’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, VRDN is a better buy in the long-term than FBLG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBLG’s TA Score shows that 3 TA indicator(s) are bullish while VRDN’s TA Score has 4 bullish TA indicator(s).

  • FBLG’s TA Score: 3 bullish, 5 bearish.
  • VRDN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VRDN is a better buy in the short-term than FBLG.

Price Growth

FBLG (@Biotechnology) experienced а -2.76% price change this week, while VRDN (@Biotechnology) price change was +13.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.31%. For the same industry, the average monthly price growth was +15.10%, and the average quarterly price growth was +1.50%.

Reported Earning Dates

FBLG is expected to report earnings on Sep 03, 2025.

VRDN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+6.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1.3B) has a higher market cap than FBLG($23.7M). VRDN YTD gains are higher at: -17.110 vs. FBLG (-69.750). FBLG has higher annual earnings (EBITDA): -7.05M vs. VRDN (-304.76M). VRDN has more cash in the bank: 637M vs. FBLG (8.67M). FBLG has less debt than VRDN: FBLG (7.12M) vs VRDN (21.2M). VRDN has higher revenues than FBLG: VRDN (302K) vs FBLG (0).
FBLGVRDNFBLG / VRDN
Capitalization23.7M1.3B2%
EBITDA-7.05M-304.76M2%
Gain YTD-69.750-17.110408%
P/E RatioN/AN/A-
Revenue0302K-
Total Cash8.67M637M1%
Total Debt7.12M21.2M34%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FBLGVRDN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
FBLG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYKCX83.14N/A
N/A
Rydex Banking C
CSRSX68.20N/A
N/A
Cohen & Steers Realty Shares L
FRMCX25.02N/A
N/A
Franklin Mutual Small-Mid Cap Val A
AFNIX25.93N/A
N/A
Bahl & Gaynor Income Growth I
QMORX23.51-0.15
-0.63%
AQR Large Cap Momentum Style R6

FBLG and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBLG has been loosely correlated with ENTO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if FBLG jumps, then ENTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBLG
1D Price
Change %
FBLG100%
-1.14%
ENTO - FBLG
38%
Loosely correlated
-1.44%
CABA - FBLG
35%
Loosely correlated
-8.59%
CCCC - FBLG
30%
Poorly correlated
+2.70%
TERN - FBLG
30%
Poorly correlated
-7.41%
ARQT - FBLG
29%
Poorly correlated
-2.69%
More